• OPEN AN ACCOUNT
Indian Indices
Sensex
83,919.71 897.96
( 1.08%)
Global Indices
Nasdaq
49,248.22 -970.95
(-1.93%)
Dow Jones
7,218.05 -126.58
(-1.72%)
Hang Seng
56,657.02 -2,787.19
(-4.69%)
Nikkei 225
10,369.59 -83.09
(-0.79%)
Forex
USD-INR
93.42 -0.12
(-0.13%)
EUR-INR
102.53 -0.37
(-0.36%)
GBP-INR
123.02 -0.43
(-0.35%)
JPY-INR
0.59 0.00
(-0.15%)

EQUITY - MARKET SCREENER

Hardwyn India Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
541276
INE626Z01029
6.0213859
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
HARDWYN
55.44
606.53
EPS(TTM)
Face Value()
Div & Yield %
0.16
1
0
 

hcl technologies ltd
Fredun Pharmaceuticals surges after Q1 PAT rises 94% YoY to Rs 13 crore
Aug 05,2026

Revenue from operations rose by 90.7% year-on-year (YoY) to Rs 227.75 crore during the period under review.

Total expenses rose by 86.6% to Rs 206.79 crore in Q1 FY27 from Rs 110.81 crore in Q1 FY26. This was primarily due to higher raw material costs (up 97.6% YoY), higher depreciation charges (up 151.6% YoY) and higher other expenses (up 52.5% YoY).

Profit before tax in Q1 FY27 stood at Rs 20.55 crore, up 127.3% from Rs 9.04 crore in Q1 FY26.

Fredun Pharmaceuticals manufactures pharmaceutical formulations such as tablets, syrups, capsules, and ointments. The company's product basket includes multiple therapeutic classes such as anti-diabetics, anti-retroviral, anti-hypertensive etc.